{5-[(2-chlorophenyl)methanesulfonyl]-1-methyl-3-(trifluoromethyl)-1H-pyrazol-4-yl}methyl propanoate

Catalog No. :
ACRPAS925
CAS No. :
955962-84-2
Molecular Formula :
C16H16ClF3N2O4S
Molecular Weight :
424.83

IUPAC Name:(5-((2-chlorobenzyl)sulfonyl)-1-methyl-3-(trifluoromethyl)-1H-pyrazol-4-yl)methyl propionate

{5-[(2-chlorophenyl)methanesulfonyl]-1-methyl-3-(trifluoromethyl)-1H-pyrazol-4-yl}methyl propanoate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name{5-[(2-chlorophenyl)methanesulfonyl]-1-methyl-3-(trifluoromethyl)-1H-pyrazol-4-yl}methyl propanoate
IUPAC Name(5-((2-chlorobenzyl)sulfonyl)-1-methyl-3-(trifluoromethyl)-1H-pyrazol-4-yl)methyl propionate
Molecular FormulaC16H16ClF3N2O4S
Molecular Weight424.83
SMILESCCC(OCC1=C(S(=O)(CC2=CC=CC=C2Cl)=O)N(C)N=C1C(F)(F)F)=O
InChI KeyGDXQAWGZJAMRHK-UHFFFAOYSA-N
Synonym[5-[(2-CHLOROBENZYL)SULFONYL]-1-METHYL-3-(TRIFLUOROMETHYL)-1H-PYRAZOL-4-YL]METHYL PROPIONATE;{5-[(2-chlorophenyl)methanesulfonyl]-1-methyl-3-(trifluoromethyl)-1H-pyrazol-4-yl}methyl propanoate;1H-Pyrazole-4-methanol, 5-[[(2-chlorophenyl)methyl]sulfonyl]-1-methyl-3-(trifluoromethyl)-, 4-propanoate
CAS No.955962-84-2

Synthetic Route by SureRoute

1. ACRPAS925 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACRPAS925 route product structure diagram
    ACRPAS925955962-84-2
Inquiry

2. ACRPAS925 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACADFR680 route compound structure diagram
    ACADFR680137-40-6 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACRPAS925 route product structure diagram
    ACRPAS925955962-84-2
Inquiry

Comments (0)